OraDisc™ Product Opportunities


Opportunity for administration of products which currently cannot be effectively delivered orally:     

  • Poor GI tract absorption.
  • Degradation by enzymes or low pH environment.
  • Extensive first-pass metabolism.
  • Delayed onset of action due to delayed absorption.

Product opportunities identified for development:     

  • Pain management (e.g. cancer pain, post surgical pain)
  • Emesis (chemotherapy induced, post surgical emesis)
  • Migraine
  • Radiation induced oral thrush
  • Enhancing weight gain (e.g. cancer and AIDS patients)

Product Opportunities-Consumer (OTC)

The mucoadhesive film technology is designed to overcome the problems associated with delivering products to the oral mucosa:

  • Saliva can rapidly wash away a topically applied active compound prior to the therapeutic benefit being achieved.
  • Action of eating, speaking, and drinking is some of the problems that have limited the usefulness of adherent pharmaceutical carriers.

Opportunities for delivery to the oral cavity include:     

  • Cough suppressant
  • Sore throat remedy
  • Antimicrobials
  • Breath freshener

Opportunities for delivery to the tooth surface include:     

  • Tooth whitening erodible strip
  • De-sensitizing strip
  • Fluoride strip
  • Enhance tooth enamel strip

More about Transmucosal Drug Delivery (OraDisc™)

More about Nanoflex® Technology